JPY 1621.0
(-1.1%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.92 Billion JPY | 1.1% |
2022 | 3.88 Billion JPY | -4.11% |
2021 | 4.04 Billion JPY | -25.07% |
2020 | 5.4 Billion JPY | 5.54% |
2019 | 5.11 Billion JPY | 12.68% |
2018 | 4.54 Billion JPY | -13.59% |
2017 | 5.25 Billion JPY | 4.95% |
2016 | 5 Billion JPY | -7.59% |
2015 | 5.41 Billion JPY | -19.05% |
2014 | 6.69 Billion JPY | -10.22% |
2013 | 7.45 Billion JPY | -6.65% |
2012 | 7.98 Billion JPY | -11.27% |
2011 | 9 Billion JPY | 22.44% |
2010 | 7.35 Billion JPY | 5.0% |
2009 | 7 Billion JPY | 13.8% |
2008 | 6.15 Billion JPY | 10.24% |
2007 | 5.58 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 3.72 Billion JPY | -5.15% |
2023 FY | 3.92 Billion JPY | 1.1% |
2023 Q1 | 3.57 Billion JPY | -7.99% |
2023 Q3 | 4.49 Billion JPY | 8.79% |
2023 Q4 | 3.92 Billion JPY | -12.65% |
2023 Q2 | 4.12 Billion JPY | 15.63% |
2022 FY | 3.88 Billion JPY | -4.11% |
2022 Q4 | 3.88 Billion JPY | -10.27% |
2022 Q3 | 4.32 Billion JPY | 9.35% |
2022 Q2 | 3.95 Billion JPY | -0.42% |
2022 Q1 | 3.97 Billion JPY | -1.86% |
2021 Q2 | 4.78 Billion JPY | 0.39% |
2021 Q4 | 4.04 Billion JPY | -11.24% |
2021 FY | 4.04 Billion JPY | -25.07% |
2021 Q1 | 4.76 Billion JPY | -11.85% |
2021 Q3 | 4.56 Billion JPY | -4.61% |
2020 Q4 | 5.4 Billion JPY | -0.48% |
2020 FY | 5.4 Billion JPY | 5.54% |
2020 Q1 | 5.28 Billion JPY | 3.17% |
2020 Q2 | 4.74 Billion JPY | -10.08% |
2020 Q3 | 5.42 Billion JPY | 14.32% |
2019 Q1 | 4.27 Billion JPY | -5.8% |
2019 FY | 5.11 Billion JPY | 12.68% |
2019 Q4 | 5.11 Billion JPY | -1.39% |
2019 Q3 | 5.19 Billion JPY | -9.97% |
2019 Q2 | 5.76 Billion JPY | 34.74% |
2018 Q2 | 4.24 Billion JPY | -7.9% |
2018 Q4 | 4.54 Billion JPY | 5.12% |
2018 FY | 4.54 Billion JPY | -13.59% |
2018 Q1 | 4.6 Billion JPY | -12.3% |
2018 Q3 | 4.32 Billion JPY | 1.78% |
2017 Q1 | 5.15 Billion JPY | 2.98% |
2017 FY | 5.25 Billion JPY | 4.95% |
2017 Q4 | 5.25 Billion JPY | 8.13% |
2017 Q3 | 4.86 Billion JPY | -8.46% |
2017 Q2 | 5.31 Billion JPY | 2.96% |
2016 Q4 | 5 Billion JPY | -3.89% |
2016 FY | 5 Billion JPY | -7.59% |
2016 Q2 | 5.52 Billion JPY | 5.9% |
2016 Q1 | 5.21 Billion JPY | -3.81% |
2016 Q3 | 5.21 Billion JPY | -5.61% |
2015 Q1 | 6 Billion JPY | -10.34% |
2015 FY | 5.41 Billion JPY | -19.05% |
2015 Q4 | 5.41 Billion JPY | 0.74% |
2015 Q3 | 5.37 Billion JPY | -3.02% |
2015 Q2 | 5.54 Billion JPY | -7.59% |
2014 FY | 6.69 Billion JPY | -10.22% |
2014 Q4 | 6.69 Billion JPY | -3.97% |
2014 Q3 | 6.97 Billion JPY | 2.38% |
2014 Q2 | 6.81 Billion JPY | 5.33% |
2014 Q1 | 6.46 Billion JPY | -13.3% |
2013 FY | 7.45 Billion JPY | -6.65% |
2013 Q4 | 7.45 Billion JPY | -2.71% |
2013 Q1 | 8.36 Billion JPY | 4.67% |
2013 Q3 | 7.66 Billion JPY | 3.57% |
2013 Q2 | 7.4 Billion JPY | -11.48% |
2012 Q4 | 7.98 Billion JPY | -1.7% |
2012 Q1 | 8.54 Billion JPY | -5.11% |
2012 Q2 | 8.04 Billion JPY | -5.81% |
2012 Q3 | 8.12 Billion JPY | 0.98% |
2012 FY | 7.98 Billion JPY | -11.27% |
2011 Q1 | 9.53 Billion JPY | 29.72% |
2011 FY | 9 Billion JPY | 22.44% |
2011 Q2 | 9.89 Billion JPY | 3.74% |
2011 Q3 | 9.28 Billion JPY | -6.18% |
2011 Q4 | 9 Billion JPY | -3.03% |
2010 Q3 | 7.6 Billion JPY | -0.94% |
2010 Q2 | 7.67 Billion JPY | 6.49% |
2010 FY | 7.35 Billion JPY | 5.0% |
2010 Q4 | 7.35 Billion JPY | -3.28% |
2010 Q1 | 7.2 Billion JPY | 2.91% |
2009 Q4 | 7 Billion JPY | -3.25% |
2009 Q3 | 7.23 Billion JPY | -3.12% |
2009 Q2 | 7.47 Billion JPY | 0.0% |
2009 FY | 7 Billion JPY | 13.8% |
2008 FY | 6.15 Billion JPY | 10.24% |
2008 Q3 | 6.04 Billion JPY | 0.0% |
2008 Q4 | 6.15 Billion JPY | 1.74% |
2007 FY | 5.58 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -137.434% |
Euglena Co., Ltd. | 37.92 Billion JPY | 89.652% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | 39.559% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 73.087% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 81.635% |
Kao Corporation | 757.7 Billion JPY | 99.482% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 58.06% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 96.042% |
Shiseido Company, Limited | 615.1 Billion JPY | 99.362% |
Lion Corporation | 188.22 Billion JPY | 97.915% |
Mandom Corporation | 20.05 Billion JPY | 80.434% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -195.757% |
Milbon Co., Ltd. | 7.45 Billion JPY | 47.395% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 71.062% |
Fancl Corporation | 30.56 Billion JPY | 87.163% |
KOSÉ Corporation | 88.61 Billion JPY | 95.572% |
Cota Co., Ltd. | 3.85 Billion JPY | -1.855% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -24.62% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 88.202% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 83.677% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -268.775% |
Almado, Inc. | 1.94 Billion JPY | -101.61% |
I-ne CO., LTD. | 8.57 Billion JPY | 54.254% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 19.588% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -1.043% |
AXXZIA Inc. | 2 Billion JPY | -95.574% |
S.T. Corporation | 12.01 Billion JPY | 67.329% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 93.737% |
Earth Corporation | 60.4 Billion JPY | 93.504% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 49.68% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -143.272% |
Ya-Man Ltd. | 3.97 Billion JPY | 1.316% |
MTG Co., Ltd. | 11.73 Billion JPY | 66.572% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | 5.944% |
SHOBIDO Corporation | 8.89 Billion JPY | 55.895% |
Artnature Inc. | 23.42 Billion JPY | 83.25% |
Pigeon Corporation | 19.34 Billion JPY | 79.719% |
Unicharm Corporation | 345.37 Billion JPY | 98.864% |
Paltac Corporation | 222.34 Billion JPY | 98.235% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 86.238% |